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Abstract
The mu-opioid receptor 1 (OPRM1) binds endogenous opioids. Increasing evidence suggests that 
endogenous OPRM1 agonists released at the time of trauma may contribute to the development of 
post-traumatic musculoskeletal pain (MSP). In this prospective observational study we evaluated 
the hypothesis that individuals with an AG or GG genotype at the OPRM1 A118G allele, which 
results in a reduced response to opioids, would have less severe MSP six weeks after motor 
vehicle collision (MVC). Based on previous evidence, we hypothesized that this effect would be 
sex-dependent and most pronounced among women with substantial peritraumatic distress. 
European American men and women ≥18 years of age presenting to the emergency department 
after MVC and discharged to home after evaluation (n=948) were enrolled. Assessments included 
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genotyping and six week evaluation of overall MSP severity (0–10 NRS). In linear regression 
modeling a significant A118G allele × sex interaction was observed: an AG/GG genotype 
predicted reduced MSP severity among women with substantial peritraumatic distress (β= −0.925, 
p=0.014), but not among all women. In contrast, men with an AG/GG genotype experienced 
increased MSP severity at six weeks (β=0.827, p=0.019). Further studies are needed to understand 
biologic mechanisms mediating observed sex differences in A118G effects.
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Opioid induced hyperalgesia; A118G; OPRM1; Motor vehicle collision; Pain
Introduction
More than 11 million Americans experience motor vehicle collision (MVC) each year; four 
million of these individuals present to US emergency departments after the MVC for 
evaluation.11 More than 90% of these individuals are discharged to home without fracture or 
other identifiable injury,39 yet persistent musculoskeletal pain (MSP) in this population is a 
common and costly public health problem.13 Mechanisms of chronic MSP development 
remain poorly understood.
One mechanism which may contribute to the development of chronic MSP after MVC is 
neuronal sensitization by endogenous opioids. Stressful events such as MVC have been 
shown to trigger the release of endogenous opioids.26, 49 The binding of endogenous opioids 
to μ-opioid receptors such as the mu-opioid receptor 1 (OPRM1) has been shown to produce 
a bimodal response: initial analgesia followed by more persistent opioid-induced 
hyperalgesia3, 14, 25, 26 (i.e., persistent OIH). The most common genetic variant in the 
OPRM1 receptor is A118G;33 the presence of a G nucleotide at A118G has been shown to 
result in reduced OPRM1 receptor binding affinity6, 42 and less OPRM1 receptor 
expression.24 This results in less mRNA in response to OPRM1 binding in those with a G 
allele, and a relative decrease in opioid effect.22, 29 Thus those with one or more copies of 
the G allele at A118G would be expected to be protected from the downstream cellular 
effects of endogenous opioids that result in persistent hyperalgesia after stress exposure. 
Consistent with this hypothesis, a recent study found that women sexual assault survivors 
with one or more copies of the G allele at A118G were found to have a reduced MSP burden 
six weeks after sexual assault compared to those with an AA genotype.4
Currently, human data supporting the contribution of endogenous OIH to persistent pain 
after stress exposure is limited to the single study of sexual assault survivors referenced 
above. The findings have not been replicated, and, in addition, no studies have assessed for 
evidence that the contribution of OIH to persistent pain outcomes is a more general 
phenomena that may apply to other stress exposures aside from rape. In the present analysis 
we used the A118G genetic variant to evaluate our primary hypothesis that OIH contributes 
to persistent MSP after MVC. Because of substantial evidence that the effect of OIH is sex-
dependent (including those of A118G17, 36), and because the G allele was found to be 
protective against persistent MSP among women sexual assault survivors, we hypothesized 
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that the protective effect of one or more copies of the G allele would be greater in women. In 
addition, because stress severity has been found to influence the magnitude of endogenous 
opioid release,26, 37, 41, 46 we hypothesized that OIH (and therefore the protective effect of a 
G allele at A118G) would be greater among women with substantial peritraumatic distress in 
the early aftermath of MVC. (All women sexual assault survivors in the previous study 
experienced substantial distress.4) Finally, because of evidence that clinical pain states may 
result in OIH,2, 15, 43 in secondary analyses we evaluated for evidence of a greater protective 
effect of A118G among individuals who reported high levels of pain prior to the MVC.
Methods
Study design and population
The details of the MVC study have been reported. In brief, individuals > 18 and ≤ 65 years 
of age presenting to one of eight emergency departments in four no-fault insurance states 
within 24 hours of MVC who did not have fracture or other injury requiring hospital 
admission were enrolled. Patients who were not alert and oriented were excluded, as were 
pregnant patients, prisoners, patients unable to read and understand English, patients taking 
a β-adrenoreceptor antagonist, or patients taking opioids above a total daily dose of 30 mg of 
oral morphine or equivalent. In addition, because genetic analyses are potentially biased by 
population stratification,12 enrollment was also limited to non-Hispanic whites (the most 
common ethnicity at study sites). Informed consent was obtained from all participants and 
IRB approval was obtained at all study sites.
DNA collection and genotyping
Study personnel collected blood samples at the time of enrollment using PAXgene DNA 
tubes. Following DNA purification (PAXgene blood DNA kit, QIAGEN, Valencia, CA, 
USA), genotyping using the Sequenom platform (Sequenom, San Diego, CA, USA) was 
performed at rs 1799971 (A118G). Two Hapmap samples and 2 repeat samples were 
included in each genotyping batch (of 96 samples). Repeated genotyping demonstrated 
>98% call agreement.
Assessments
Overall pain intensity in the emergency department and during the month prior to MVC 
were assessed using verbal 0–10 numeric rating scales (NRSs). Verbal scores have 
advantages in acute care settings, and verbally administered NRSs have been validated as a 
substitute for Visual Analog Scales in the emergency department.7 Past pain scores were 
calculated by summing the 0–10 pain severity scores from each of 20 body regions (scale of 
0–200). Individuals reporting a score of 10 or more were defined as having high levels of 
past pain. This cut-off of 10 was used because (1) this represents the top quartile of pre-
MVC pain in this relatively young, healthy study cohort, (2) although the scale has a high 
upper range, a score of 10 represents several regions of moderate or severe pain or a large 
number of body regions with some pain. (Average overall pain intensity in the past week (0–
10 NRS) was evaluated six weeks after the MVC via web-based questionnaire or telephone 
interview. Stress severity in the emergency department was measured using the 
Peritraumatic Distress Inventory.9 The Peritraumatic Distress Inventory is a 13 item 
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questionnaire assessing life threat, loss of control, helplessness/anger, and guilt/shame that 
results in a score between 0–52. Individuals with a score of 23 or higher were considered to 
have significant peritraumatic distress.35
Statistical Analysis
Sample sociodemographic characteristics were summarized using standard descriptive 
statistics. Linear regression models were used to compare pain intensity levels six weeks 
following MVC in individuals with AA vs GA/GG genotypes at OPRM1 polymorphism 
rs1799971. To adjust for potential confounding factors, models were adjusted for age, 
income, education, and emergency department study site by adding them as independent 
variables to the model. Emergency department study site was added as a categorical variable 
and thus resulted in eight distinct variables in the models. Because they are not of interest or 
relevant to the study hypotheses other than as potential confounders, categorical variables 
representing study site location are not shown in the tables. Additionally, to adjust for any 
effect of A118G on pain prior to MVC or on acute pain, models were also adjusted for pain 
at the time of initial evaluation and pain prior to MVC.
In addition to primary analyses, subgroup analyses were performed on subsets of individuals 
with a) peritraumatic distress and b) high prior pain. Statistical significance of A118G effect 
was determined via linear regression model t-statistic. Covariate-adjusted least-square 
means and corresponding standard errors for pain scores according to A118G genotype were 
also obtained from model outputs. All statistical analyses were completed using SPSS 
software (v.21; SPSS Inc, Chicago, IL). P-values < 0.05 were considered statistically 
significant.
Results
Study Enrollment, Follow-Up, and Genotyping
A total of 10,629 patients were screened, 1,416 were eligible, 969 consented to study 
participation and 948 completed baseline evaluation. Six week follow-up assessments were 
completed on 859/948 (91%) of enrolled patients. All study participants provided blood for 
DNA genotyping; the genotyping call rate at A118G was >98% and the SNP was in Hardy-
Weinberg equilibrium. Consistent with HapMap database and a previous large population-
based study,8 the prevalence of the G allele at A118G this European American sample was 
~23% (214/948).
Characteristics of the Study Sample
Characteristics of the study sample are shown in Table 1. Most individuals had completed at 
least some college, were married, worked full time, and had an annual income of $40,000 or 
more. Fractures were present in 1/948 (<1%, phalanx fracture) participants, a small 
laceration was present in 53/948 (6%) participants. The vast majority of study participants 
had musculoskeletal strain only. More than one third of participants (355, 37%) reported 
substantial peritraumatic distress in the emergency department, nearly three quarters of those 
with peritraumatic distress (256, 72%) were female. There was no difference in 
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peritraumatic distress symptom severity among individuals without and with one or more G 
alleles (19.1 (9.9) vs. 19.2 (10.3), t = 0.140, p =0.886).
Evaluation for sex-dependent influence of A118G on 6 week MSP outcomes
We first evaluated whether the influence of A118G on six week MSP outcomes was sex-
dependent. As shown in Table 2, a significant allele-sex interaction was observed (β = 1.059, 
p = 0.017). All remaining analyses were therefore stratified on patient sex.
Influence of A118G Genotype on 6 week MSP outcomes among all women and among 
women with substantial peritraumatic distress
The influence of A118G on six week MSP outcomes among women study participants (n = 
575) is shown in Table 3. Point estimates for overall MSP six weeks after MVC were lower 
among women with one or more copies of the G allele at A118G (4.0 (3.5, 4.6) vs 4.3 (3.4, 
4.7), p = 0.304), but no statistically significant difference was observed. When analyses 
were limited to women with substantial peritraumatic distress (n = 256), the protective effect 
of having one or more G alleles was more pronounced and statistically significant. Women 
with peritraumatic distress and one or more copies of the G allele had lower overall MSP six 
weeks after MVC than those with an AA genotype (3.6 (2.9, 4.8) vs 4.7 (4.1, 5.3), p = 0.014, 
Figure 1).
Influence of A118G Genotype on 6 week MSP outcomes among all men and among men 
with substantial peritraumatic distress
The influence of A118G on six week MSP outcomes among male study participants (n = 
373) is shown in Table 3. In contrast to women, men with one or more copies of the G allele 
at A118G had increased overall MSP six weeks after MVC (4.0 (3.3, 4.7) vs. 3.1 (2.7, 3.5), 
p = 0.019). When analyses were limited to men with substantial peritraumatic distress (n = 
99, Table 3), point estimates for overall MSP six weeks after MVC were higher among those 
with one or more copies of the G allele than those with an AA genotype (4.5 (2.2, 6.7) vs. 
4.1 (2.6, 5.6), p = 0.672, Figure 1), but no statistically significant difference was observed.
Secondary analyses evaluating A118G genotype influence on 6 week MSP outcomes 
among individuals with a history of pre-MVC pain
Secondary analyses evaluated for the presence of OIH among individuals who reported the 
greatest pain severity prior to MVC (average MSP severity during the month prior to MVC 
in this top quartile was 22.5 (14.7)). Among women with the highest pain severity prior to 
MVC (n = 97, Table 4a), mean overall MSP score six weeks after MVC was lower among 
those with one or more copies of the G allele at A118G (2.4 (0.7, 4.1) vs 4.1 (2.9, 5.2); p = 
0.028). Point estimates for mean MSP score six weeks after MVC were higher for men with 
substantial pain prior to MVC (n = 50, Table 4a) and at least one G allele at A118G, 
however this difference was not statistically significant (6.5 (4.4, 8.7) vs 5.4 (4.4, 6.4); p = 
0.310, data not shown).
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Discussion
To our knowledge, this is the first study evaluating the effect of a genetic variant influencing 
opioid system function on persistent MSP symptoms after MVC. In a previous study of 
European American women sexual assault survivors, all of whom had substantial 
peritraumatic distress,4 those with a common genetic polymorphism in OPRM1 which 
reduces the biological effect of receptor binding (one or more G alleles at A118G) 
experienced less MSP in the first six weeks after assault.4 These results, together with 
previous data demonstrating that (1) stress exposure results in the release of endogenous 
opioids18, 26, 27, 43 and (2) stress-induced endogenous opioid release causes OIH26, 46, 
support the hypothesis that endogenous OIH contributed to persistent MSP in the weeks 
after assault. Results from the present study of MVC survivors provides further support for 
the hypothesis that, among women trauma survivors experiencing substantial distress, 
endogenous OIH might contribute to persistent MSP in the weeks after trauma. In addition, 
these results suggest a specific mechanism by which an emotional response to a traumatic 
event (distress) may contribute to a specific biologic mechanism (endogenous opioid 
release) that increases MSP in the weeks after a trauma exposure. In the future, this 
information may be useful in helping to tailor secondary preventive interventions (e.g., low 
dose naloxone) for particular trauma survivor subgroups. The consistency of this finding 
among women experiencing substantial distress after both sexual assault and MVC suggests 
that this mechanism may contribute to MSP in the weeks after other trauma exposures as 
well. However, future experiments will be necessary in order to fully substantiate this 
possibility.
In contrast to the previous study of sexual assault survivors, in which all study participants 
were women with substantial peritraumatic distress, the present MVC cohort study provided 
the opportunity to evaluate the influence of A118G allele on MSP outcomes among men and 
among both distressed and non-distressed women. The modest effect of A118G among all 
women indicates that OIH has an effect on MSP symptoms in the weeks after trauma only 
among women with substantial peritraumatic distress. While not significant, point estimates 
in stratified analyses suggested that the effect of the G allele may be protective against pain 
in women and may be associated with augmented pain in men. Of note, when peritraumatic 
distress is added to the linear regression model for all individuals, a sex difference in the 
effect of A118G is still observed. Point estimates for men vs women are consistent with 
results from several previous studies. Fillingim et al found opposite effects of A118G on 
experimental heat pain among men and women, with the presence of a G allele associated 
with decreased pain in men and increased pain in women.17 Similarly, Olsen et al found 
opposite effects on pain outcomes after low back surgery among men and women, with the 
presence of a G allele associated with decreased pain in men and increased pain in women.36 
In contrast to these studies, Lotsch et al found that healthy men and women volunteers with 
one or more copies of the G allele at A118G experienced decreased cortical activation 
following acute experimental pain stimuli28
Reasons for the varying direction of sex-dependent effects of A118G across studies remain 
poorly understood. Regarding varied findings, one contributing factor is likely the varied 
nature of the trauma/stress exposures and the timing of the outcome assessment across 
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studies. Increasing evidence indicates that both the nature of the stress or pain exposure and 
the timing of outcome assessments impact pain mechanisms.23, 30 Ethnic differences in 
study populations also likely contribute to differences across study settings.5, 21
Within-study sex differences in the effect of A118G variants on pain outcomes are also 
poorly understood, and may be due to fundamental sex differences in neural circuits in the 
brain and spinal cord mediating stress-induced analgesia and opioid responses (reviewed 
in32). For example, at equal levels of pain intensity, men and women have been shown to 
differ in the magnitude and direction of response to μ-opioid system activation in distinct 
brain nuclei,50 and female rats have been shown to exhibit more pronounced OIH in 
response to morphine injection, which is thought to be mediated via melanocortin 1 receptor 
versus NMDA type glutamate receptor involvement in females versus males, 
respectively.10, 20, 34 The effect of opioid systems on other critical stress systems, which also 
modulate neurosensory processing, such as the hypothalamic-pituitary-adrenal axis or 
inflammatory factors, has also been shown to be sex-dependent.40, 47
Secondary analyses in the present study suggest that the protective effect of a G allele at 
A118G was greater among those with the highest levels of pre-MVC pain. These results are 
consistent with the findings of Rivat et al, who found that in rats that are pain experienced 
stress induces hyperalgesia, not analgesia, through an NMDA-dependent pronociceptive 
mechanism.43 Together these data suggest that prior life experiences play a substantial role 
in shaping pain responses to stress, and that opioid systems may contribute to this 
phenomenon.
As we have previously reported, we observed significant associations between baseline 
income and education levels at the time of trauma and worse pain outcomes after MVC,31, 48 
with lower income and education generally associated with worse pain outcomes. These 
findings are consistent with those of other studies,1, 16 and demonstrate the influence of 
sociodemographic characteristics on pain outcomes following trauma exposure.
Several limitations should be considered when interpreting our study results. First, some 
women in the study sample received exogenous opioids, and this could have contributed to 
our study results. However, when individuals who received opioids in the emergency 
department (n = 284) and/or in the weeks after MVC (n = 168) were removed from analyses, 
effect size differences for the presence of one or more copies of the G allele did not change 
(data not shown). Similarly, in the previously reported sexual assault study, the effect of 
A118G on pain outcomes did not change when women receiving exogenous opioids were 
removed from analyses.4 Another limitation of our study is our small sample size and 
evaluation of a single polymorphism. Previously, we showed association between FKBP5 
and COMT genes with 6 week pain outcomes; when adding the tagging alleles from these 
previous studies to the current models for A118G, the associations remain significant (data 
not shown). In addition, we were also not able to assess the effects of ethnicity on our 
findings since only European American individuals were enrolled in this study. Finally, 
another limitation of this study is that, consistent with other studies enrolling trauma 
survivors19, 44, 45 and the challenges of performing ethical studies of traumatized individuals 
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in the acute aftermath of trauma, this study did not enroll all eligible study participants. The 
generalizability of our results to those who declined enrollment is not known.
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Perspective
These results suggest a sex-dependent mechanism by which an emotional response to 
trauma (distress) contributes to a biologic mechanism (endogenous opioid release) that 
increases MSP in the weeks after stress exposure. These results also support the 
hypothesis that endogenous opioids influence pain outcomes differently in men and 
women.
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Highlights
- We examined the effect of OPRM1 A118G on persistent pain following 
MVC stress
- Women with a G allele and distress at the time of MVC had reduced pain at 6 
weeks
- Men with a G allele had increased pain 6 weeks following MVC
- Results show a sex dependent effect of A118G on pain development 
following stress
- Effect of OPRM1 allele on pain after stress suggests endogenous OIH 
mechanism
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Figure 1. 
Mean overall pain levels associated with AA versus AG/GG genotypes at OPRM1 allele 
A118G 6 weeks after MVC in men and women with and without peritraumatic distress. Pain 
levels were measured on a scale of 0–10 (NRS). Males = diamonds and females = circles. P 
values were calculated via multivariate analyses adjusted for site, age, education, income, 
pain prior to MVC and pain at the time of initial evaluation. Error bars represent the 
standard error of the mean.
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Table 1
Baseline characteristics of study participants
Characteristic All (n=948) Female (575, 61%) Male (373, 39%)
Age (mean, SD) 35 (13) 35 (13) 35 (13)
Education (n, %)
 Secondary school 283 (30) 150 (26) 133 (36)
 Some college 312 (33) 172 (30) 140 (38)
 College graduate/post-graduate 351 (37) 252 (44) 99 (27)
Income (n, %)
 $0–$19,999 117 (12) 84 (16) 33 (10)
 $20,000–$39,999 176 (19) 115 (22) 61 (19)
 $40,000–$79,999 277 (29) 178 (35) 99 (30)
 $80,000 or higher 273 (29) 139 (36) 131 (41)
Collision type (n, %)
 Front end 439 (46) 262 (46) 177 (48)
 Rear end 340 (36) 206 (36) 134 (36)
Relationship (n, %)
 No serious relationship 297 (31) 178 (31) 119 (32)
 In a serious relationship 267 (29) 171 (30) 96 (26)
 Married 371 (39) 217 (38) 154 (42)
Peritraumatic Distress (n, %) 355 (37) 256 (47) 99 (28)
Genotype (n, %)
 AA 732 (77) 442 (77) 290 (78)
 AG 197 (21) 123 (21) 74 (20)
 GG 17 (2) 9 (2) 8 (2)
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Table 2
Linear regression model results demonstrating a main effect of OPMR1 allele A118G on overall pain severity 
six weeks after motor vehicle collision (MVC) and an A118G-sex interaction (n = 859)
Independent variablea Beta SE P
A118G (presence or absence of G allele) 0.815 0.358 0.023
Female Sex 0.857 0.222 <0.001
A118G allele * Sex −1.059 0.446 0.017
Age 0.023 0.007 0.001
Education −0.249 0.072 0.001
Income −0.164 0.054 0.003
Pain at the time of initial evaluation 0.046 0.004 <0.001
Pain prior to MVC 0.025 0.041 0.549
aStudy site was also included in model as a categorical variable
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Table 3
General linear models examining the relationship of OPRM1 allele A118G on overall pain severity six weeks 
after motor vehicle collision (MVC) among all men and women and among men and women with substantial 
peritraumatic distress after MVC
Independent variablea Beta SE P
In all women (n = 575)
 A118G allele −0.264 0.268 0.324
 Age 0.013 0.009 0.146
 Education −0.291 0.091 0.001
 Income −0.185 0.068 0.007
 Pain at the time of initial evaluation 0.044 0.006 0.000
 Pain prior to MVC 0.014 0.051 0.780
In women with peritraumatic distress (n = 256)
 A118G allele −0.925 0.375 0.014
 Age 0.022 0.013 0.100
 Education −0.170 0.135 0.205
 Income −0.230 0.102 0.024
 Pain at the time of initial evaluation 0.041 0.008 <0.001
 Pain prior to MVC 0.035 0.070 0.621
In men (n = 373)
 A118G allele 0.827 0.352 0.019
 Age 0.041 0.011 0.000
 Education −0.197 0.115 0.086
 Income −0.121 0.090 0.179
 Pain at the time of initial evaluation 0.049 0.007 <0.001
 Pain prior to MVC 0.066 0.070 0.347
In men with peritraumatic distress (n = 99)
 A118G allele 0.340 0.802 0.672
 Age 0.070 0.025 0.006
 Education 0.115 0.242 0.636
 Income −0.255 0.169 0.132
 Pain at the time of initial evaluation 0.039 0.010 <0.001
 Pain prior to MVC 0.041 0.117 0.728
aStudy site was also included in model as a categorical variable
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Table 4
a. General linear model examining the relationship of OPRM1 allele A118G with overall pain intensity 6 weeks following MVC in 
women reporting high levels of pain prior to MVC
Independent variablea Beta SE P
In women with high pain prior to MVCb (n = 97)
 A118G allele −1.727 0.507 0.001
 Age 0.017 0.017 0.309
 Education −0.182 0.168 0.276
 Income −0.565 −0.840 <0.001
 Pain at the time of initial evaluation 0.226 0.093 0.015
b. Linear regression model examining the relationship of OPRM1 allele A118G with overall pain intensity 6 weeks following MVC in 
men reporting high levels of pain prior to MVC
Independent variablea Beta SE P
In men with high pain prior to MVCb (n = 50)
 A118G allele 1.742 0.914 0.057
 Age 0.065 0.031 0.034
 Education −0.530 −0..269 0.049
 Income 0.100 0.224 0.656
 Pain at the time of initial evaluation 0.646 0.133 <0.001
aStudy site was also included in model as a categorical variable
b
High pain prior to MVC was defined by a score of 10 or more (top quartile of individuals)
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